Arancha Cebrián

1.7k total citations
50 papers, 1.3k citations indexed

About

Arancha Cebrián is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Arancha Cebrián has authored 50 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 21 papers in Molecular Biology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Arancha Cebrián's work include Cancer-related Molecular Pathways (7 papers), Neuroendocrine Tumor Research Advances (6 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Arancha Cebrián is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Neuroendocrine Tumor Research Advances (6 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Arancha Cebrián collaborates with scholars based in Spain, United Kingdom and United States. Arancha Cebrián's co-authors include Juan Carlos Lacal, Teresa Gómez del Pulgar, Mercedes Robledo, Paul D.P. Pharoah, Javier Benı́tez, Alison M. Dunning, Douglas F. Easton, Sergio Ruiz‐Llorente, Jesús García‐Foncillas and Laura del Puerto‐Nevado and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Arancha Cebrián

49 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arancha Cebrián Spain	22	647	320	279	249	188	50	1.3k
Myriem Boufraqech United States	23	1.1k 1.7×	366 1.1×	450 1.6×	540 2.2×	113 0.6×	45	1.8k
Loris Bertazza Italy	21	373 0.6×	281 0.9×	428 1.5×	256 1.0×	74 0.4×	60	1.1k
Bingyin Shi China	25	1.1k 1.7×	342 1.1×	460 1.6×	355 1.4×	154 0.8×	87	1.9k
Rong Bu Saudi Arabia	26	718 1.1×	412 1.3×	195 0.7×	371 1.5×	170 0.9×	61	1.5k
Hisaya Kawate Japan	21	1.3k 2.0×	348 1.1×	286 1.0×	319 1.3×	98 0.5×	58	1.9k
Antonella Verrienti Italy	24	652 1.0×	310 1.0×	1.0k 3.6×	287 1.2×	315 1.7×	74	1.8k
K Dohi Japan	16	528 0.8×	380 1.2×	305 1.1×	190 0.8×	128 0.7×	87	1.3k
Seiji Inoshita Japan	19	1.0k 1.6×	184 0.6×	108 0.4×	137 0.6×	80 0.4×	38	1.5k
Chung‐Ying Tsai Taiwan	25	980 1.5×	222 0.7×	267 1.0×	707 2.8×	210 1.1×	57	1.6k
Christophe Marçais France	16	366 0.6×	171 0.5×	219 0.8×	138 0.6×	192 1.0×	28	1.1k

Countries citing papers authored by Arancha Cebrián

Since Specialization

Citations

This map shows the geographic impact of Arancha Cebrián's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arancha Cebrián with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arancha Cebrián more than expected).

Fields of papers citing papers by Arancha Cebrián

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arancha Cebrián. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arancha Cebrián. The network helps show where Arancha Cebrián may publish in the future.

Co-authorship network of co-authors of Arancha Cebrián

This figure shows the co-authorship network connecting the top 25 collaborators of Arancha Cebrián. A scholar is included among the top collaborators of Arancha Cebrián based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arancha Cebrián. Arancha Cebrián is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cebrián, Arancha, Laura del Puerto, José Antonio Pellicer, et al.. (2024). Vitamin‐C ‐dependent downregulation of the citrate metabolism pathway potentiates pancreatic ductal adenocarcinoma growth arrest. Molecular Oncology. 18(9). 2212–2233. 4 indexed citations

Mateos‐Gómez, Pedro A., Laura del Puerto‐Nevado, Óscar Aguilera, et al.. (2024). Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells. British Journal of Cancer. 130(8). 1402–1413. 9 indexed citations

Lacal, Juan Carlos, Rosario Perona, Javier de Castro, & Arancha Cebrián. (2022). Choline Kinase α Inhibitors MN58b and RSM932A Enhances the Antitumor Response to Cisplatin in Lung Tumor Cells. Pharmaceutics. 14(6). 1143–1143. 3 indexed citations

Puerto‐Nevado, Laura del, et al.. (2022). Galectin-1, a novel promising target for outcome prediction and treatment in SCLC. Biomedicine & Pharmacotherapy. 156. 113987–113987. 6 indexed citations

Cebrián, Arancha, et al.. (2021). Improving selection of patients with metastatic colorectal cancer to benefit from cetuximab based on KIR genotypes. Journal for ImmunoTherapy of Cancer. 9(4). e001705–e001705. 8 indexed citations

Rodríguez‐Remírez, María, Laura del Puerto‐Nevado, María Jesús Fernández‐Aceñero, et al.. (2019). Strong Antitumor Activity of Bevacizumab and Aflibercept in Neuroendocrine Carcinomas: In-Depth Preclinical Study. Neuroendocrinology. 110(1-2). 50–62. 9 indexed citations

Fernández‐Aceñero, María Jesús, M. I. Cruz, J. Ignacio Casal, et al.. (2019). TRIM72 Immunohistochemical Expression Can Predict Relapse in Colorectal Carcinoma. Pathology & Oncology Research. 26(2). 861–865. 13 indexed citations

Cruz‐Ramos, Marlid, Laura del Puerto‐Nevado, Binbin Zheng-Lin, et al.. (2018). Prognostic significance of neutrophil-to lymphocyte ratio and platelet-to lymphocyte ratio in older patients with metastatic colorectal cancer. Journal of Geriatric Oncology. 10(5). 742–748. 23 indexed citations

Martínez‐Useros, Javier, T. Georgiev-Hristov, María Jesús Fernández‐Aceñero, et al.. (2017). UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept. PLoS ONE. 12(8). e0182044–e0182044. 15 indexed citations

10.

Rodríguez‐Remírez, María, Pablo Mínguez, Arancha Cebrián, et al.. (2016). P-041 IKAROS: a potential prognostic marker in pancreatic ductal adenocarcinoma. Annals of Oncology. 27. ii12–ii12.

11.

Martínez‐Useros, Javier, T. Georgiev-Hristov, María Jesús Fernández‐Aceñero, et al.. (2015). Identification of Poor-outcome Biliopancreatic Carcinoma Patients With Two-marker Signature Based on ATF6α and p-p38 “STARD Compliant”. Medicine. 94(45). e1972–e1972. 5 indexed citations

12.

Martínez‐Useros, Javier, María Rodríguez‐Remírez, Irene Moreno, et al.. (2014). DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer. BMC Cancer. 14(1). 965–965. 24 indexed citations

13.

Molina, Ana Ramı́rez de, Rosario Machado-Pinilla, Vanessa Rodríguez‐Fanjul, et al.. (2012). Acid Ceramidase as a Chemotherapeutic Target to Overcome Resistance to the Antitumoral Effect of Choline Kinase α Inhibition. Current Cancer Drug Targets. 12(6). 617–624. 21 indexed citations

14.

Gallego‐Ortega, David, Teresa Gómez del Pulgar, Fátima Valdés‐Mora, Arancha Cebrián, & Juan Carlos Lacal. (2010). Involvement of human choline kinase alpha and beta in carcinogenesis: A different role in lipid metabolism and biological functions. Advances in Enzyme Regulation. 51(1). 183–194. 52 indexed citations

15.

Casado‐Vela, Juan, Arancha Cebrián, Elsa Sánchez‐López, et al.. (2010). Lights and shadows of proteomic technologies for the study of protein species including isoforms, splicing variants and protein post‐translational modifications. PROTEOMICS. 11(4). 590–603. 25 indexed citations

16.

Cebrián, Arancha, Paul D.P. Pharoah, Shahana Ahmed, et al.. (2006). Tagging Single-Nucleotide Polymorphisms in Antioxidant Defense Enzymes and Susceptibility to Breast Cancer. Cancer Research. 66(2). 1225–1233. 68 indexed citations

17.

Cebrián, Arancha, Paul D.P. Pharoah, Shahana Ahmed, et al.. (2006). Genetic variants in epigenetic genes and breast cancer risk. Carcinogenesis. 27(8). 1661–1669. 75 indexed citations

18.

García, María J., et al.. (2002). Different Incidence and Pattern of p15INK4b and p16INK4a Promoter Region Hypermethylation in Hodgkin's and CD30-Positive Non-Hodgkin's Lymphomas. American Journal Of Pathology. 161(3). 1007–1013. 47 indexed citations

19.

Bolaños, Luis, Arancha Cebrián, Miguel Redondo‐Nieto, Rafael Rivilla, & Ildefonso Bonilla. (2001). Lectin-Like Glycoprotein PsNLEC-1 Is Not Correctly Glycosylated and Targeted in Boron-Deficient Pea Nodules. Molecular Plant-Microbe Interactions. 14(5). 663–670. 38 indexed citations

20.

Osório, Ana, Mercedes Robledo, Beatriz Fernández-Martínez, et al.. (1998). Molecular analysis of the BRCA2 gene in 16 breast/ovarian cancer Spanish families. Clinical Genetics. 54(2). 142–147. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact